ClinicalTrials.gg

ST Elevation Myocardial Infarction clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 853 studies for ST Elevation Myocardial Infarction across more than 10 countries. 199 are recruiting or about to start. 619 of them are mainly about ST Elevation Myocardial Infarction (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-17.

ClinicalTrials.gov finds 1,309 studies for ST Elevation Myocardial Infarction. How that becomes 850 here

This page counts the studies the registry files under ST Elevation Myocardial Infarction, and those it files under no condition that list ST Elevation Myocardial Infarctionthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 1,309Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −7List ST Elevation Myocardial Infarction as a condition, but the registry did not file them under itMost often written as “Acute ST Elevation Myocardial Infarction” (1), “Segment Elevation Myocardial Infarction (STEMI)” (1), and “Patients With ST-elevated Myocardial Infarction” (1). The registry filed them under other conditions only, most often Myocardial Infarction (2) and Angina, Stable (2).
  3. −452Match it another way218 name it in the title, 10 in a keyword, and 224 by a synonym or other text the search reads.
  4. 850The count on this page21 of them list ST Elevation Myocardial Infarction in their own words; the registry filed them under no condition.

Status

Completed
362
Status unknown
192
Recruiting
122
Not yet recruiting
72
Terminated
39
Active, not recruiting
34

Phase

Phase 4
117
Phase 3
96
Phase 2
89
Phase 1
14
Early Phase 1
2

Where

China
146
United States
82
Italy
70
United Kingdom
52
France
49
Germany
49

Who develops what

Add ST Elevation Myocardial Infarction to watchlistPro · free during the betaEvery Monday by email · turn it off any time

Every program with a company-led study here in the last two years, whatever its size: 5 programs from 4 companies, 2 with this as their studies’ main aim; 1 with a live phase 3 study; 4 primary completions in the next 12 months.

Comparator & background therapies

What other companies’ phase 2+ studies give as the comparator or the background here (its leading trial sponsor and partners left out): a sign of what new drugs are measured against, not by itself the standard of care, its prescriptions or its market.

DrugLeading trial sponsor · rightsCompanies, last 5 years
TenecteplaseRecent, limited
Evidence
  • NCT05601999 · ao generium · Phase 3 · comparator · “Metalyse” · registered Oct 2022
Boehringer Ingelheim50% of its industry studiesEU: Boehringer Ingelheim (EMA 2001)11 study
ClopidogrelEarlier only
Evidence
  • NCT00557921 · Cogentus Pharmaceuticals · Phase 3 · comparator · “Plavix (clopidogrel 75 mg) and aspirin” · registered Nov 2007
  • NCT00305162 · Novartis · Phase 3 · background · “clopidogrel (oral P2Y12 inhibitor)” · registered Mar 2006
Sanofi35% of its industry studiesUS: off-patent, 13 generics marketedEU: off-patent, 11 generics authorized00 studies

Programs

“Meets, by arms” reads each study’s arms: vs its arm against the therapy’s; + X vs a combination against it; added to it plus the therapy against the therapy; studied with given together only. The next primary completion is the next phase-3 study’s when there is one.

The 5 programs — sign in to see the whole list, free: filter by phase and aim, sort by late development, direct comparisons or the next primary completion.

Primary completion in the next 12 months (4)

Live phase 2 and 3 studies of these programs. Primary completion is when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced.

  • 16 Jan 2027 est.inclisiran · Novartis · Phase 3 registry mapping onlyNCT07102628 Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronary Syndromes — primary endpoint: Percent change in LDL-C · 305 enrolled
  • Apr 2027 est.SGC001 · Beijing Sungen Biomedical Technology Co., Ltd · Phase 2 main aimNCT07306182 A Research Study to Evaluate the Efficacy and Safety of SGC001 in Patients With Anterior Wall ST-Segment Elevation Myocardial Infarction — primary endpoint: Percentage of myocardial infarction size(ratio of infarct mass to left ventricular mass) · 210 enrolled
  • 30 Jun 2027 est.Xolatryp · Nyrada Pty Ltd · Phase 2 main aimNCT07362446 Prevention of Reperfusion Injury Outcomes Through Effective Cardioprotection Targeting Myocardial Infarction — primary endpoint: Incidence of Adverse Events · 300 enrolled

1 more — sign in to see them all, free.

Read from ClinicalTrials.gov, industry-led studies. Main aim: this is the study’s judged main condition; named, not the main aim: the sponsor names it, the study is about something else; registry mapping only: only the registry’s mapping put it here. Leading trial sponsor is the company leading the most industry studies of a drug, a measure of trial activity, not of rights. US and EU rights, and Approved: from the regulators’ records (FDA’s Drugs@FDA via openFDA; EMA’s medicines data) — the holder of a marketed or authorized original, generics and other companies’ versions; not rights elsewhere, nor approval for this condition. Phase 4 trial recorded, where neither lists it: a phase 4 study exists somewhere. Not read yet: labels by indication, exclusivity, licenses, line of therapy, academic comparators, sales.

What is being tested here

Drugs under test in ST Elevation Myocardial Infarction studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug classes tested here SGLT2 inhibitors 6 open · Statins 2 open · PCSK9 inhibitors 2 open · Thrombolytics 1 open · Corticosteroids 1 open

Coming up

65studies finish main data collection within a year4 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 122 ST Elevation Myocardial Infarction studies recruiting now, 76 (62%) set no upper age limit and 20 (16%) stop at 75 or younger. 10 (8%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 9 (7%) take healthy volunteers.

Recruiting studies that take each age, of 122
AgeWomenMen
108 (7%)8 (7%)
18112 (92%)112 (92%)
30119 (98%)119 (98%)
40121 (99%)121 (99%)
50120 (98%)120 (98%)
65120 (98%)120 (98%)
75115 (94%)115 (94%)
8581 (66%)81 (66%)

Across all 853 studies, recruiting or not: 14% stop at 75 or younger and 2% at 65; 9% take children; <1% are for women only and <1% for men only; 4% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long ST Elevation Myocardial Infarction studies take

Of 49 phase 4 interventional studies under ST Elevation Myocardial Infarction, half reached primary completion within 34 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 226 mo14–39 · 31 studies——
Phase 337 mo23–58 · 38 studies——
Phase 434 mo22–63 · 49 studies—34 mo21–74 · 44 studies
Interventional, no phase38 mo19–64 · 143 studies—38 mo19–64 · 134 studies
Observational38 mo20–73 · 143 studies—41 mo18–107 · 122 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 18, 2026.

Studies

Recruiting first, then most recently updated. Showing 50 of 853. Browse all 853 → or search them.